Contribution: Industrial Research Assistance Program – Contributions to Firms
WeedMD Rx. Inc.
$173,971.00
Cannabis - Optimization of Cannabinoid Yield from Plant Growth Optimization and Improved Extraction Processes
FY 2018-19 · 2018-04-01
Summary
We will conduct detailed study to optimize the production of cannabis and the cannabinoid profile throughout the growth stages.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Aylmer|Aylmer, Ontario, Canada
Recipient Type
For-profit organization
Business Number
818430449
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-04-01 | 2018-19 | $173,971.00 |
| 1 | 2018-04-01 | 2018-19 | $173,971.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 122 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 122 jours.
Agreement End Date
2019-06-30
Agreement Number
906927
Agreement Start Date
2018-04-01
Agreement Title
Cannabis - Optimization of Cannabinoid Yield from Plant Growth Optimization and Improved Extraction Processes
Agreement Title (French)
Cannabis - Optimisation du rendement en cannabinoïdes à partir de l'optimisation de la croissance des plantes et l'amélioration des processus d'extraction
Agreement Type
Contribution
Agreement Value
$173,971.00
Amendment Date
2019-01-10
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
We will conduct detailed study to optimize the production of cannabis and the cannabinoid profile throughout the growth stages.
Description (French)
Nous mènerons une étude détaillée pour optimiser la production de cannabis et le profil des cannabinoïdes au cours des stades de croissance.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Elgin--Middlesex--London
Federal Riding (French)
Elgin--Middlesex--London
Federal Riding Number
35025
NAICS Code
111412
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
818430449
Recipient City
Aylmer|Aylmer
Recipient Country
CA
Recipient Legal Name
WeedMD Rx. Inc.
Recipient Postal Code
N5H 2M8
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q1-906927
